The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size is expected to reach US$ 696.7 million by 2029, growing at a CAGR of 10.2% from 2023 to 2029. The market is mainly driven by the significant applications of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in various end use industries. The expanding demands from the Government Tender and Market Sales, are propelling Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market. Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines covered in this report include CAHIC, Boehringer Ingelheim, MSD Animal Health, Sino Pharm, Ceva, ChengDu Tecbond, Ringpu Biology, Qilu Animal and DHN, etc.
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CAHIC
Boehringer Ingelheim
MSD Animal Health
Sino Pharm
Ceva
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tecon
Zoetis
WINSUN
PULILE
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, Segment by Type:
Live Vaccines
Killed Vaccines
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, by Application
Government Tender
Market Sales
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size is expected to reach US$ 696.7 million by 2029, growing at a CAGR of 10.2% from 2023 to 2029. The market is mainly driven by the significant applications of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in various end use industries. The expanding demands from the Government Tender and Market Sales, are propelling Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market. Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines covered in this report include CAHIC, Boehringer Ingelheim, MSD Animal Health, Sino Pharm, Ceva, ChengDu Tecbond, Ringpu Biology, Qilu Animal and DHN, etc.
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CAHIC
Boehringer Ingelheim
MSD Animal Health
Sino Pharm
Ceva
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tecon
Zoetis
WINSUN
PULILE
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, Segment by Type:
Live Vaccines
Killed Vaccines
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market, by Application
Government Tender
Market Sales
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Overview
1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
1.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
1.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2023)
2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competition by Company
2.1 Global Top Players by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2018-2023)
2.2 Global Top Players by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2023)
2.3 Global Top Players by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Situation and Trends
2.5.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market
2.8 Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Status and Outlook by Region
3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Region
3.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Region
3.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Application
4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segment by Application
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2023)
5 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country
5.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Country
5.1.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2018-2023)
5.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Country
5.2.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2024-2029)
6 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country
6.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Country
6.1.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Country
6.2.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Region
7.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2024-2029)
8 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country
8.1 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Country
8.1.1 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Country
8.2.1 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country
9.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CAHIC
10.1.1 CAHIC Company Information
10.1.2 CAHIC Introduction and Business Overview
10.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.1.5 CAHIC Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 MSD Animal Health
10.3.1 MSD Animal Health Company Information
10.3.2 MSD Animal Health Introduction and Business Overview
10.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.3.5 MSD Animal Health Recent Development
10.4 Sino Pharm
10.4.1 Sino Pharm Company Information
10.4.2 Sino Pharm Introduction and Business Overview
10.4.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.4.5 Sino Pharm Recent Development
10.5 Ceva
10.5.1 Ceva Company Information
10.5.2 Ceva Introduction and Business Overview
10.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.5.5 Ceva Recent Development
10.6 ChengDu Tecbond
10.6.1 ChengDu Tecbond Company Information
10.6.2 ChengDu Tecbond Introduction and Business Overview
10.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.6.5 ChengDu Tecbond Recent Development
10.7 Ringpu Biology
10.7.1 Ringpu Biology Company Information
10.7.2 Ringpu Biology Introduction and Business Overview
10.7.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.7.5 Ringpu Biology Recent Development
10.8 Qilu Animal
10.8.1 Qilu Animal Company Information
10.8.2 Qilu Animal Introduction and Business Overview
10.8.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.8.5 Qilu Animal Recent Development
10.9 DHN
10.9.1 DHN Company Information
10.9.2 DHN Introduction and Business Overview
10.9.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.9.5 DHN Recent Development
10.10 CAVAC
10.10.1 CAVAC Company Information
10.10.2 CAVAC Introduction and Business Overview
10.10.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.10.5 CAVAC Recent Development
10.11 Komipharm
10.11.1 Komipharm Company Information
10.11.2 Komipharm Introduction and Business Overview
10.11.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.11.5 Komipharm Recent Development
10.12 Agrovet
10.12.1 Agrovet Company Information
10.12.2 Agrovet Introduction and Business Overview
10.12.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.12.5 Agrovet Recent Development
10.13 Bioveta
10.13.1 Bioveta Company Information
10.13.2 Bioveta Introduction and Business Overview
10.13.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.13.5 Bioveta Recent Development
10.14 Jinyu Bio-Technology
10.14.1 Jinyu Bio-Technology Company Information
10.14.2 Jinyu Bio-Technology Introduction and Business Overview
10.14.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.14.5 Jinyu Bio-Technology Recent Development
10.15 Phibro Animal Health
10.15.1 Phibro Animal Health Company Information
10.15.2 Phibro Animal Health Introduction and Business Overview
10.15.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.15.5 Phibro Animal Health Recent Development
10.16 Tecon
10.16.1 Tecon Company Information
10.16.2 Tecon Introduction and Business Overview
10.16.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.16.5 Tecon Recent Development
10.17 Zoetis
10.17.1 Zoetis Company Information
10.17.2 Zoetis Introduction and Business Overview
10.17.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.17.5 Zoetis Recent Development
10.18 WINSUN
10.18.1 WINSUN Company Information
10.18.2 WINSUN Introduction and Business Overview
10.18.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.18.5 WINSUN Recent Development
10.19 PULILE
10.19.1 PULILE Company Information
10.19.2 PULILE Introduction and Business Overview
10.19.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.19.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.19.5 PULILE Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industrial Chain Analysis
11.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Dynamics
11.4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
11.4.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
11.4.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
11.4.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
12.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
